FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes new monoester compounds of the general formula (I): Nu-O-Fa where values Nu and Fa are given in p. 1 of the invention claim. Compounds can be used for treatment of humans and animals suffering with the viral infection. Invention describes also a pharmaceutical composition based on compounds of the formula (I). EFFECT: new compounds indicated above, an antiviral activity. 8 cl, 17 dwg, 1 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NUCLEOSIDE ESTERS AND PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2126417C1 |
| DERIVATIVES OF ARABINOFURANOSYLCYTOSINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 1996 |
|
RU2165260C2 |
| DERIVATIVES OF HEMCYTABINE | 1998 |
|
RU2194711C2 |
| PHARMACEUTICAL COMPOSITIONS | 1995 |
|
RU2176144C2 |
| DIOXOLANE DERIVATIVES FOR CANCER TREATMENT | 2006 |
|
RU2418795C2 |
| COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS | 2007 |
|
RU2525392C2 |
| COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS | 2007 |
|
RU2466729C2 |
| MODIFIED 2- AND 3-NUCLEOSIDES AND USE THEREOF TO PRODUCE MEDICINAL AGENT, HAVING HEPATITIS C INHIBITING ACTIVITY | 2003 |
|
RU2437892C2 |
| PROMEDICINES OF MODIFIED 2'- AND 3'-NUCLEOSIDES FOR TREATMENT OF FLAVIVIRIDAE INFECTIONS | 2003 |
|
RU2366661C2 |
| MODIFIED 2'- AND 3'-NUCLEOSIDES AND USE THEREOF FOR PREPARING DRUG FOR TREATING FLAVIVIRIDAE INFECTIONS | 2011 |
|
RU2483075C2 |
